Compare Automatic Data Processing Inc (ADP) vs Sana Biotechnology Inc (SANA) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Automatic Data Processing Inc vs Sana Biotechnology Inc — how do they compare? Automatic Data Processing Inc trades at $241.65 (market cap $98.17B), while Sana Biotechnology Inc trades at $3.98 (market cap $1.15B). The key difference: Automatic Data Processing Inc is far larger — about 85.4× Sana Biotechnology Inc's market cap, and Automatic Data Processing Inc pays a 2.77% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| ADP | SANA | |
|---|---|---|
Market Cap | $98.17B | $1.15B |
Sector | Industrials | Health |
52-Week High | $310.94 | $5.92 |
52-Week Low | $188.79 | $2.68 |
Enterprise Value | $99.24B | $1.12B |
Dividend Yield | 2.77% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Automatic Data Processing Inc
ADP is a provider of payroll and human capital management solutions servicing the full scope of businesses from micro to global enterprises. ADP was established in 1949 and serves over 990,000 clients primarily in the United States. ADP's employer services segment offers payroll, HCM solutions, HR outsourcing, insurance and retirement services. The smaller but faster-growing PEO segment provides HR outsourcing solutions to small and midsize businesses through a co-employment model.
Read more on ADP →About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →
